Description

Lengo Therapeutics is a biotechnology company focused on developing novel, small-molecule precision therapeutics targeting driver mutations in oncology.

Round Leads

Amount Raised

Prior to its acquisition, Lengo Therapeutics had raised approximately $17.7 million.

We've made it simple to share your company's profile with other investors

Copyright 2024 - All Right Reserved

Copyright 2024 - All Right Reserved

Copyright 2024 - All Right Reserved

Description

Lengo Therapeutics is a biotechnology company focused on developing novel, small-molecule precision therapeutics targeting driver mutations in oncology.

Round Leads

Amount Raised

Prior to its acquisition, Lengo Therapeutics had raised approximately $17.7 million.

We've made it simple to share your company's profile with other investors

Copyright 2024 - All Right Reserved

Copyright 2024 - All Right Reserved

Description

Lengo Therapeutics is a biotechnology company focused on developing novel, small-molecule precision therapeutics targeting driver mutations in oncology.

Round Leads

Amount Raised

Prior to its acquisition, Lengo Therapeutics had raised approximately $17.7 million.

We've made it simple to share your company's profile with other investors